Tenaya Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.8% | +8.4% | -11.7% | -13.9% | -14.7% | +20.0% | -15.1% | -14.1% | +40.0% | -8.1% | -30.7% | |
| – | -12.0% | +15.3% | -18.4% | -18.8% | -21.0% | +40.2% | -19.7% | -19.3% | +72.4% | -8.5% | -10.9% | |
| – | -44.4% | +29.8% | -2.0% | -85.8% | -47.5% | +1,143.9% | +16.5% | -10.1% | +78.6% | -19.6% | -3.5% | |
| – | -14.1% | +16.8% | -18.8% | -20.0% | -22.7% | +43.5% | -18.7% | -21.4% | +78.6% | -19.6% | -3.5% | |
| – | – | – | – | – | – | – | – | – | – | – | -96.5% | |
| – | +9.0% | -14.1% | +9.2% | -4.1% | -3.2% | -9.3% | -9.1% | -0.9% | +7.0% | +22.1% | -16.4% | |
| – | +17.3% | -15.7% | -12.8% | -3.2% | -1.2% | -11.4% | -10.6% | +4.4% | +16.9% | +8.7% | +13.3% | |
| – | +36.9% | -5.9% | -17.2% | -10.5% | -7.7% | +0.6% | +1.4% | +3.2% | +3.2% | +3.1% | -7.6% | |
| – | -4.6% | +18.3% | -35.1% | +35.2% | -11.6% | -1.9% | -34.9% | -13.8% | +26.0% | -46.6% | +51.6% | |
| – | -15.4% | +13.5% | -15.3% | -16.0% | -17.5% | +28.6% | -16.4% | -17.0% | +48.7% | -13.9% | -34.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.6% | +18.5% | +5.8% | +0.5% | +0.3% | +27.2% | +48.2% | +0.3% | -6.4% | +41.8% | +0.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.